Loading...

FULC FULCRUM THERAPEUTICS INC Capital Structure Changes 8-K Filing

FLCR

FLC

FULCRUM THERAPEUTICS INC

(FULC)

2024 8-K

Financial Results Announced

Corporate Update

Stock Offering Details

Clinical Trial Results

Quarterly Results

Corporate Presentation Update

Clinical Trials

Financial Statements

Agreement Termination

Financial Results

Financial Update

Agreement Termination

Financial Results

Workforce Reduction

Equity Exchange

Financial Results Announcement

Board Expansion and New Dir...

Collaboration and License A...

Financial Results Announcement

Financial Results Announcement

FDA Clinical Hold Lifted

Financial Results and Manag...

Annual Meeting Approval

Financial Results and Manag...

Resignation of CFO

Financial Results Announcement

Public Offering

Financial Condition

Management Changes

External Links:

Fulcrum Therapeutics exchanged shares with RA Capital and another institutional stockholder, issuing pre-funded warrants for a total of 9,350,000 shares, which are immediately exercisable at a low price and have ownership limits.

AI Assistant

FULCRUM THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.